Louis C. Lucido is President of BioCorRx Inc.. Currently has a direct ownership of 2.51 Million shares of BICX, which is worth approximately $778,701. The most recent transaction as insider was on Dec 31, 2024, when has been sold 57,018 shares (Common Stock, par value $0.001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.51M
4.69% 3M change
409.31% 12M change
Total Value Held $778,701

Louis C. Lucido Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2024
BUY
Grant, award, or other acquisition
-
57,018 Added 2.22%
2,511,940 Common Stock, par valu...
Nov 29 2024
BUY
Grant, award, or other acquisition
-
55,494 Added 2.21%
2,454,922 Common Stock, par valu...
Oct 31 2024
BUY
Grant, award, or other acquisition
-
55,556 Added 2.26%
2,399,428 Common Stock, par valu...
Oct 14 2024
BUY
Grant, award, or other acquisition
-
1,105,218 Added 32.04%
2,343,872 Common Stock, par valu...
Sep 30 2024
BUY
Grant, award, or other acquisition
-
67,710 Added 5.18%
1,238,654 Common Stock, par valu...
Aug 30 2024
BUY
Grant, award, or other acquisition
-
55,559 Added 4.53%
1,170,944 Common Stock, par valu...
Jul 31 2024
BUY
Grant, award, or other acquisition
-
32,092 Added 2.8%
1,115,385 Common Stock, par valu...
Jun 28 2024
BUY
Grant, award, or other acquisition
-
44,220 Added 6.63%
622,816 Common Stock, par valu...
May 31 2024
BUY
Grant, award, or other acquisition
-
22,831 Added 3.8%
578,596 Common Stock, par valu...
Apr 30 2024
BUY
Grant, award, or other acquisition
-
21,552 Added 3.73%
555,765 Common Stock, par valu...
Apr 24 2024
BUY
Other acquisition or disposition
-
460,477 Added 29.83%
1,083,293 Common Stock, par valu...
Mar 28 2024
BUY
Grant, award, or other acquisition
-
24,119 Added 4.32%
534,213 Common Stock, par valu...
Feb 29 2024
BUY
Grant, award, or other acquisition
-
16,892 Added 3.21%
510,094 Common Stock, par valu...
Jan 31 2024
BUY
Grant, award, or other acquisition
-
18,269 Added 3.57%
493,202 Common Stock, par valu...
Jan 16 2024
BUY
Open market or private purchase
$88 $0.7 p/Share
126 Added 0.03%
474,933 Common Stock, par valu...
Jan 12 2024
BUY
Open market or private purchase
$2,100 $0.7 p/Share
3,000 Added 0.63%
474,807 Common Stock, par valu...
Jan 02 2024
BUY
Grant, award, or other acquisition
-
6,173 Added 1.29%
471,807 Common Stock, par valu...
Sep 29 2023
BUY
Grant, award, or other acquisition
-
2,858 Added 0.61%
465,634 Common Stock, par valu...
Jun 30 2023
BUY
Grant, award, or other acquisition
-
2,891 Added 0.62%
462,776 Common Stock, par valu...
Apr 03 2023
BUY
Other acquisition or disposition
-
183,606 Added 28.53%
459,885 Common Stock, par valu...
Mar 31 2023
BUY
Grant, award, or other acquisition
-
2,824 Added 2.62%
104,983 Common Stock, par valu...
Jan 30 2023
BUY
Open market or private purchase
$552 $1.38 p/Share
400 Added 0.39%
102,159 Common Stock, par valu...
Jan 26 2023
BUY
Open market or private purchase
$645 $1.29 p/Share
500 Added 0.49%
101,759 Common Stock, par valu...
Jan 24 2023
BUY
Open market or private purchase
$240 $1.2 p/Share
200 Added 0.2%
101,259 Common Stock, par valu...
Jan 13 2023
BUY
Open market or private purchase
$4,520 $1.13 p/Share
4,000 Added 3.81%
101,059 Common Stock, par valu...
LCL

Louis C. Lucido

President
Anaheim, CA

Track Institutional and Insider Activities on BICX

Follow BioCorRx Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BICX shares.

Notify only if

Insider Trading

Get notified when an Bio Cor Rx Inc. insider buys or sells BICX shares.

Notify only if

News

Receive news related to BioCorRx Inc.

Track Activities on BICX